RB
RE
Retro Biosciences
A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.
About
Retro Biosciences is a biotechnology startup dedicated to increasing healthy human lifespan by nine years. The company focuses on researching and developing therapies that address the fundamental biological processes of aging, aiming to translate scientific discoveries into clinical applications.
Key facts
At-a-glance profile data
- Website
- retrobiosciences.com
- Headquarters
- Redwood City, United States
- Founded
- 2021
- Total funding
- $180M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 6 Sept 2022 | Seed | $180M | - |
Add first review
Frequently asked
How much funding has Retro Biosciences raised?
Retro Biosciences has raised a total of $180M in funding. The most recent round on record is Seed.
What is Retro Biosciences's current status?
Retro Biosciences's current operating status is: Inactive.